Takeda Pharmaceutical Company is a company that provides research-based healthcare and medical products. The company was founded by Chobei Takeda I in 1781, in Osaka, Osaka, Japan.
The company is primarily patient-focused, research and development driven, and is interested in biopharmaceuticals. The company operates in the United States with 18,000 employees. The company looks to develop pharmaceutical products and conduct corporate citizenship activities.
Takeda Pharmaceutical Company has announced a plan of action in response to COVID-19. Their plan since the outbreak of the virus is to develop a plasma-derived therapy; an anti-SARS-CoV-2 polyclonal-hyper-immune-globuli that is designed specifically for high risk patients.
The company's therapy includes concentrated pathogen-specific antibodies that are derived from plasma of recovered patients. Takeda Pharmaceuticals Company believes the antibodies have the potential to generate an immune response when injected into a new patient.
Director of Computational Biology
Documentaries, videos and podcasts
Takeda Pharmaceutical Company
Osaka, Osaka, Japan
Pharmaceuticals and vaccinations
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.
- HealthcareDiagnosis, treatment and prevention of disease, illness, and injury
- CoronavirusCDC Coronavirus: Coronaviruses are common throughout the world. They can infect people and animals. Five different coronaviruses can infect people and make them sick. They usually cause mild to moderate upper-respiratory illness.
- Cluster: COVID-19A cluster of topics related to COVID-19. COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the WHO.
- Convalescent serumThe serum component of blood, containing pathogen-neutralizing antibodies, drawn from an individual who has recovered from an infection and which is administered to others as disease prevention or treatment.